InvestorsHub Logo
Followers 35
Posts 6308
Boards Moderated 0
Alias Born 02/09/2015

Re: None

Thursday, 12/03/2015 8:10:21 AM

Thursday, December 03, 2015 8:10:21 AM

Post# of 403773
New competitor: COTI-2. Novel small molecule(sound familiar) that restores p53 function starting phase 1 at MD Anderson- who knows when. For use in Li Fraumeni and other tumors, the usuaul suspects.

Oh yeah- an oral agent.

Way behind K in development of course, at this point.